Michael Plastow
Physician Assistant · Springfield, MONPI 1366748873
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 652 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AstraZeneca at 24.8% of the total. Among physician assistant clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 652 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- CSL Behring$2K
- GSK$885
- Sanofi$778
- Novartis$554
- Amgen$510
- plus $4K from 21 others
What the payments were for
- Food & beverage$11,25599%
- Education$851%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 146 | $2,817 |
| CSL Behring | 122 | $2,022 |
| GSK | 59 | $885 |
| Sanofi | 43 | $778 |
| Novartis | 30 | $554 |
| Amgen(2 entities) | 31 | $510 |
| Pharming Healthcare, Inc. | 30 | $492 |
| Optinose US, Inc. | 33 | $461 |
| Grifols USA, LLC | 24 | $459 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $431 |
| Pfizer | 26 | $387 |
| Regeneron Healthcare Solutions, Inc. | 19 | $378 |
| Boehringer Ingelheim | 21 | $331 |
| Genentech USA, Inc. | 10 | $165 |
| Teva Pharmaceuticals USA, Inc. | 9 | $128 |
| Neurocrine Biosciences, Inc. | 1 | $76 |
| Incyte Corporation | 4 | $75 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $69 |
| Biocryst US Sales Co., LLC | 3 | $55 |
| Blueprint Medicines Corporation | 3 | $53 |
| Merck | 3 | $49 |
| Kaleo, Inc. | 3 | $48 |
| Octapharma USA, Inc. | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $30 |
| Lilly USA, LLC | 1 | $18 |
| Alk-abello, Inc | 1 | $16 |
| LEO Pharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$123
How this compares
$11,341 in reported general payments places this provider in the 95th percentile of 1,380 physician assistant providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 83 | $74,523 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 71 | $48,837 |
| Spiriva RespimatTiotropium Bromide | 52 | $29,563 |
| Breo ElliptaFluticasone/Vilanterol | 64 | $25,321 |
| Advair HfaFluticasone Propion/Salmeterol | 39 | $15,651 |
| Arnuity ElliptaFluticasone Furoate | 21 | $5,581 |
| Epinephrine | 26 | $4,780 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $4,171 |
| Azelastine Hcl | 121 | $2,534 |
| Ipratropium Bromide | 75 | $1,501 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 15 | $1,455 |
| Fluticasone Propionate | 99 | $1,133 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $1,130 |
| Montelukast Sodium | 156 | $980 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $502 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $885 | $105,426168 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,817 | $53,00893 claims |
| Boehringer IngelheimSpiriva Respimat | $331 | $29,56352 claims |
| Hikma Pharmaceuticals USAEpinephrine | $30 | $4,78026 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,380 physician assistant providers in Missouri.
Other physician assistant in Springfield
- Marc ReitznerSpringfield$24K
- Morgan KuhnSpringfield$16K
- James RivesSpringfield$8K
- Jodie TuckerSpringfield$8K
- Lauren CoppSpringfield$8K
- Amanda GoddardSpringfield$7K
- Jennifer DavissonKansas City$343K
- Andrew BergLees Summit$245K
- Sileen DowisKansas City$117K
- Daniel BeckSikeston$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.